Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-28T18:51:33.602Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of three-dimensional silver-doped borate bioactive glass scaffolds for bone repair: Biodegradability, biocompatibility, and antibacterial activity

Published online by Cambridge University Press:  25 August 2015

Hui Wang ,
Shichang Zhao ,
Xu Cui ,
Yangyi Pan ,
Wenhai Huang ,
Song Ye ,
Shihua Luo ,
Mohamed N. Rahaman ,
Changqing Zhang  and
Deping Wang
Hui Wang
Affiliation:
Department of Materials Science and Engineering, Institute of Bioengineering and Information Technology Materials, Tongji University, Shanghai 200092, China
Shichang Zhao
Affiliation:
Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
Xu Cui
Affiliation:
School of Materials Science and Engineering, Tongji University, Shanghai 200092, China
Yangyi Pan
Affiliation:
School of Materials Science and Engineering, Tongji University, Shanghai 200092, China
Wenhai Huang
Affiliation:
School of Materials Science and Engineering, Tongji University, Shanghai 200092, China
Song Ye
Affiliation:
School of Materials Science and Engineering, Tongji University, Shanghai 200092, China
Shihua Luo
Affiliation:
Department of Orthopaedic Surgery, Shanghai Jiaotong University Affiliated Ruijing Hospital, Shanghai 200233, China
Mohamed N. Rahaman
Affiliation:
Department of Materials Science and Engineering, and Center for Biomedical Science and Engineering, Missouri University of Science and Technology, Rolla, Missouri 65409, USA
Changqing Zhang*
Affiliation:
Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
Deping Wang*
Affiliation:
School of Materials Science and Engineering, Tongji University, Shanghai 200092, China
*
b)e-mail: shzhangchangqing@163.com
a)Address all correspondence to these authors. e-mail: wdpshk@tongji.edu.cn
Get access

Abstract

The development of synthetic scaffolds with a desirable combination of properties, such as bioactivity, the ability to locally deliver antibacterial agents and high osteogenic capacity, is a challenging but promising approach in bone tissue engineering. In this study, scaffolds of a borosilicate bioactive glass (composition: 6Na2O, 8K2O, 8MgO, 22CaO, 36B2O3, 18SiO2, 2P2O5; mol%) with controllable antibacterial activity were developed by doping the parent glass with varying amounts of Ag2O (0.05, 0.5, and 1.0 wt%). The addition of the Ag2O lowered the compressive strength and degradation of the bioactive glass scaffolds but it did not affect the formation of hydroxyapatite on the surface of the glass as determined by energy dispersive x-ray analysis, x-ray diffraction, and Fourier transform infrared analysis. The Ag2O-doped scaffolds showed a sustained release of Ag ions over more than 8 weeks in simulated body fluid and resistance against colonization by the bacterial strains Escherichia coli and Staphylococcus aureus. In vitro cell culture showed better adhesion, proliferation, and alkaline phosphatase activity of murine osteoblastic MC3T3-E1 cells on the Ag2O-doped bioactive glass scaffolds than on the undoped scaffolds. The results indicate that these Ag-doped borosilicate bioactive glass scaffolds may have potential in repairing bone coupled with providing a lower risk of bacterial infection.

Keywords

borosilicate bioactive glassscaffoldssilver-doped bioactive glassbioactive glass conversionantibacterial activitybiocompatibility
Type
Articles
Information
Journal of Materials Research , Volume 30 , Issue 18 , 28 September 2015 , pp. 2722 - 2735
Copyright
Copyright © Materials Research Society 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Yang, F., Wang, J., Hou, J., Guo, H., and Liu, C.S.: Bone regeneration using cell-mediated responsive degradable PEG-based scaffolds incorporating with rhBMP-2. Biomaterials 34(5), 1514 (2013).Google Scholar
Pauksch, L., Hartmann, S., Rohnke, M., Szalay, G., Alt, V., Schnettler, R., and Lips, K.S.: Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater. 10(1), 439 (2014).CrossRefGoogle ScholarPubMed
Renaud, A., Lavigne, M., and Vendittoli, P-A.: Periprosthetic joint infections at a teaching hospital in 1990–2007. Can. J. Surg. 55(6), 394 (2012).Google Scholar
Henslee, A.M., Spicer, P.P., Yoon, D.M., Nair, M.B., Meretoja, V.V., Witherel, K.E., Jansen, J.A., Mikos, A.G., and Kasper, F.K.: Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomater. 7(10), 3627 (2011).Google Scholar
Ye, J.H., Xu, Y.J., Gao, J., Yan, S.G., Zhao, J., Tu, Q.S., Zhang, J., Duan, X.J., Sommer, C.A., Mostoslavsky, G., Kaplan, D.L., Wu, Y.N., Zhang, C.P., Wang, L., and Chen, J.: Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs. Biomaterials 32(22), 5065 (2011).CrossRefGoogle Scholar
Cao, W. and Hench, L.L.: Bioactive materials. Ceram. Int. 22(6), 493 (1996).CrossRefGoogle Scholar
Tsigkou, O., Jones, J.R., Polak, J.M., and Stevens, M.M.: Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass® conditioned medium in the absence of osteogenic supplements. Biomaterials 30(21), 3542 (2009).Google Scholar
Sun, J., Wei, L., Liu, X., Li, J., Li, B., Wang, G., and Meng, F.: Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression. Acta Biomater. 5(4), 1284 (2009).CrossRefGoogle ScholarPubMed
Liang, W., Rahaman, M.N., Day, D.E., Marion, N.W., Riley, G.C., and Mao, J.J.: Bioactive borate glass scaffold for bone tissue engineering. J. Non-Cryst. Solids 354(15), 1690 (2008).Google Scholar
Zhang, X., Jia, W., Gu, Y., Xiao, W., Liu, X., Wang, D., Zhang, C., Huang, W., Rahaman, M.N., and Day, D.E.: Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials 31(22), 5865 (2010).Google Scholar
Han, X. and Day, D.E.: Reaction of sodium calcium borate glasses to form hydroxyapatite. J. Mater. Sci.: Mater. Med. 18(9), 1837 (2007).Google Scholar
Huang, W., Day, D.E., Kittiratanapiboon, K., and Rahaman, M.N.: Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J. Mater. Sci.: Mater. Med. 17(7), 583 (2006).Google Scholar
Nielsen, F.H.: The emergence of boron as nutritionally important throughout the life cycle. Nutrition 16(7), 512 (2000).Google Scholar
Durand, L.A.H., Gongora, A., Lopez, J.M.P., Boccaccini, A.R., Zago, M.P., Baldi, A., and Gorustovich, A.: In vitro endothelial cell response to ionic dissolution products from boron-doped bioactive glass in the SiO2-CaO-P2O5-Na2O system. J. Mater. Chem. B 2(43), 7620 (2014).CrossRefGoogle Scholar
Forrer, R., Wenker, C., Gautschi, K., and Lutz, H.: Concentration of 17 trace elements in serum and whole blood of plains viscachas (Lagostomus maximus) by ICP-MS, their reference ranges, and their relation to cataract. Biol. Trace Elem. Res. 81(1), 47 (2001).CrossRefGoogle ScholarPubMed
Forrer, R., Gautschi, K., and Lutz, H.: Simultaneous measurement of the trace elements Al, As, B, Be, Cd, Co, Cu, Fe, Li, Mn, Mo, Ni, Rb, Se, Sr, and Zn in human serum and their reference ranges by ICP-MS. Biol. Trace Elem. Res. 80(1), 77 (2001).Google Scholar
Bi, L., Jung, S., Day, D., Neidig, K., Dusevich, V., Eick, D., and Bonewald, L.: Evaluation of bone regeneration, angiogenesis, and hydroxyapatite conversion in critical‐sized rat calvarial defects implanted with bioactive glass scaffolds. J. Biomed. Mater. Res., Part A 100(12), 3267 (2012).CrossRefGoogle ScholarPubMed
Gristina, A.G., Naylor, P.T., and Myrvik, Q.N.: Biomaterial-centered infections: Microbial adhesion versus tissue integration. In Pathogenesis of Wound and Biomaterial-Associated Infections, (Springer, London, UK, 1990); p. 193.Google Scholar
Choi, O., Deng, K.K., Kim, N-J., Ross, L. Jr., Surampalli, R.Y., and Hu, Z.: The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 42(12), 3066 (2008).Google Scholar
Kalishwaralal, K., BarathManiKanth, S., Pandian, S.R.K., Deepak, V., and Gurunathan, S.: Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis . Colloids Surf., B 79(2), 340 (2010).Google Scholar
Moojen, D.J.F., Spijkers, S.N., Schot, C.S., Nijhof, M.W., Vogely, H.C., Fleer, A., Verbout, A.J., Castelein, R.M., Dhert, W.J., and Schouls, L.M.: Identification of orthopaedic infections using broad-range polymerase chain reaction and reverse line blot hybridization. J. Bone Jt. Surg. 89(6), 1298 (2007).Google Scholar
Harris, L., Tosatti, S., Wieland, M., Textor, M., and Richards, R.: Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly (l-lysine)-grafted-poly (ethylene glycol) copolymers. Biomaterials 25(18), 4135 (2004).Google Scholar
Clement, J.L. and Jarrett, P.S.: Antibacterial silver. Met.-Based Drugs 1(5–6), 467 (1994).CrossRefGoogle ScholarPubMed
Percival, S., Bowler, P., and Russell, D.: Bacterial resistance to silver in wound care. J. Hosp. Infect. 60(1), 1 (2005).Google Scholar
Liu, X., Huang, W., Fu, H., Yao, A., Wang, D., Pan, H., and Lu, W.W.: Bioactive borosilicate glass scaffolds: Improvement on the strength of glass-based scaffolds for tissue engineering. J. Mater. Sci.: Mater. Med. 20(1), 365 (2009).Google ScholarPubMed
Kokubo, T. and Takadama, H.: How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 27(15), 2907 (2006).Google Scholar
King, G.N., King, N., and Hughes, F.J.: Effect of two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration in vivo. J. Periodontal Res. 33(3), 226 (1998).Google Scholar
Zheng, F., Wang, S., Wen, S., Shen, M., Zhu, M., and Shi, X.: Characterization and antibacterial activity of amoxicillin-loaded electrospun nano-hydroxyapatite/poly (lactic-co-glycolic acid) composite nanofibers. Biomaterials 34(4), 1402 (2013).Google Scholar
Erol, M., Mouriňo, V., Newby, P., Chatzistavrou, X., Roether, J., Hupa, L., and Boccaccini, A.R.: Copper-releasing, boron-containing bioactive glass-based scaffolds coated with alginate for bone tissue engineering. Acta Biomater. 8(2), 792 (2012).Google Scholar
Boronin, A., Koscheev, S., and Zhidomirov, G.: XPS and UPS study of oxygen states on silver. J. Electron Spectrosc. Relat. Phenom. 96(1–3), 43 (1998).Google Scholar
Liu, X., Rahaman, M.N., and Day, D.E.: Conversion of melt-derived microfibrous borate (13-93B3) and silicate (45S5) bioactive glass in a simulated body fluid. J. Mater. Sci.: Mater. Med. 24(3), 583 (2013).Google Scholar
Jones, J.R. and Hench, L.L.: Factors affecting the structure and properties of bioactive foam scaffolds for tissue engineering. J. Biomed. Mater. Res., Part B 68(1), 36 (2004).CrossRefGoogle ScholarPubMed
Ma, Z., Kotaki, M., Inai, R., and Ramakrishna, S.: Potential of nanofiber matrix as tissue-engineering scaffolds. Tissue Eng. 11(1–2), 101 (2005).Google Scholar
Baer, C., Foldbjerg, R., Hayashi, Y., Sutherlans, D.S., and Autrup, H.: Toxicity of silver nanoparticles—Nanoparticle or silver ion? Toxicol. Lett. 208, 286 (2012).Google Scholar
Kittler, S., Greulich, C., Diendorf, J., Koller, M., and Epple, M.: Toxicity of silver nanoparticles increases during storage because of dissolution of slow dissolution under release of silver ions. Chem. Mater. 22, 4548 (2010).Google Scholar
Park, M.V., Neigh, A.M., Vermeulen, J.P., de la Fonteyne, L.J., Verharen, H.W., Briedé, J.J., and van Loveren, H. and de Jong, W.H.: The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 32(36), 9810 (2011).CrossRefGoogle ScholarPubMed
AshaRani, P., Low Kah Mun, G., Hande, M.P., and Valiyaveettil, S.: Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3(2), 279 (2008).CrossRefGoogle Scholar
Rai, M., Yadav, A., and Gade, A.: Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27(1), 76 (2009).CrossRefGoogle ScholarPubMed
Albers, C.E., Hofstetter, W., Siebenrock, K.A., Landmann, R., and Klenke, F.M.: In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 7(1), 30 (2013).CrossRefGoogle ScholarPubMed
Ewald, A., Hösel, D., Patel, S., Grover, L.M., Barralet, J.E., and Gbureck, U.: Silver-doped calcium phosphate cements with antimicrobial activity. Acta Biomater. 7(11), 4064 (2011).CrossRefGoogle ScholarPubMed
Hunt, C.D.: Dietary boron: Progress in establishing essential roles in human physiology. J. Trace Elem. Med. Biol. 26(2), 157 (2012).CrossRefGoogle ScholarPubMed
Park, M., Li, Q., Shcheynikov, N., Zeng, W., and Muallem, S.: NaBC1 is a ubiquitous electrogenic Na+-coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol. Cell 16(3), 331 (2004).CrossRefGoogle ScholarPubMed
Gorustovich, A.A., López, J.M.P., Guglielmotti, M.B., and Cabrini, R.L.: Biological performance of boron-modified bioactive glass particles implanted in rat tibia bone marrow. Biomed. Mater. 1(3), 100 (2006).CrossRefGoogle ScholarPubMed
Reddy, K.M., Feris, K., Bell, J., Wingett, D.G., Hanley, C., and Punnoose, A.: Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl. Phys. Lett. 90(21), 213902 (2007).Google Scholar
Kohanski, M.A., Dwyer, D.J., and Collins, J.J.: How antibiotics kill bacteria: From targets to networks. Nat. Rev. Microbiol. 8(6), 423 (2010).CrossRefGoogle ScholarPubMed
Brogden, K.A.: Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3(3), 238 (2005).Google Scholar
Supplementary material: Image

Wang supplementary material S1

Supplementary Figure

Download Wang supplementary material S1(Image)
Image 120.6 KB
Supplementary material: Image

Wang supplementary material S2

Supplementary Figure

Download Wang supplementary material S2(Image)
Image 134.7 KB